Eric  Miller

Dr. Eric Miller

Haverford College, Haverford, United States
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MAMonica I. Abrudan
Monica I. Abrudan
FSFokko Smakman
Fokko Smakman
AGArd Jan Grimbergen
Ard Jan Grimbergen
SWSanne Westhoff
Sanne Westhoff
EMEric Miller
Eric Miller
DRDaniel E. Rozen
Daniel E. Rozen
Significance: Antibiotics have profoundly changed human medicine, yet we know surprisingly little about the role of antibiotics in nature for the bacteria that produce them. Here we examine antibiotic use in the prolific antibiotic-producing genus Streptomyces across divergent social and competitive growth conditions. Our results provide clear experimental evidence that antibiotics are weapons whose use is strongly modified by intermicrobial social interactions. Simultaneously, using experiments and computer simulations, we show that social and competitive dynamics between bacteria have a crucial and previously unrecognized influence on the maintenance of microbial diversity in soil environments. These insights have implications for both bacterial coexistence and diversity and also for drug discovery.

18 July 2008 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
MCMatthew C. Cowperthwaite
Matthew C. Cowperthwaite
EEEvan P. Economo
Evan P. Economo
WHWilliam R. Harcombe
William R. Harcombe
EMEric Miller
Eric Miller
LMLauren Ancel Meyers
Lauren Ancel Meyers
Evolution by natural selection is fundamentally shaped by the fitness landscapes in which it occurs. Yet fitness landscapes are vast and complex, and thus we know relatively little about the long-range constraints they impose on evolutionary dynamics. Here, we exhaustively survey the structural landscapes of RNA molecules of lengths 12 to 18 nucleotides, and develop a network model to describe the relationship between sequence and structure. We find that phenotype abundance—the number of genotypes producing a particular phenotype—varies in a predictable manner and critically influences evolutionary dynamics. A study of naturally occurring functional RNA molecules using a new structural statistic suggests that these molecules are biased toward abundant phenotypes. This supports an “ascent of the abundant” hypothesis, in which evolution yields abundant phenotypes even when they are not the most fit. Evolutionary biology tells us much about the immediate fate of a mutation once it appears, but relatively little about its long-term evolutionary implications. Major evolutionary transitions from one trait to another may depend on a long sequence of interacting mutations, each arising by chance and surviving natural selection. In this study, we characterize the network of mutations that connect diverse molecular structures, and find that this network biases evolution toward traits that are readily produced by one or a short sequence of mutations. This bias may prevent the evolution of optimal traits, a phenomenon they call the “ascent of the abundant.”

3 February 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MKMorten Kjos
Morten Kjos
EMEric Miller
Eric Miller
JSJelle Slager
Jelle Slager
FLFrank B. Lake
Frank B. Lake
OGOliver Gericke
Oliver Gericke
JVJan-Willem Veening
Jan-Willem Veening
Pneumococcal bacteriocins (pneumocins) are antibacterial toxins that mediate intra-species competition within the human host. However, the triggers of pneumocin expression are poorly understood. Using RNA-sequencing, we mapped the regulon of the pneumocin cluster (blp) of Streptococcus pneumoniae D39. Furthermore, by analogy with pneumococcal competence, we show that several antibiotics activate the blp-genes. Using real-time gene expression measurements we show that while the promoter driving expression of the two-component regulatory system blpR/H is constitutive, the remaining blp-promoters that control pneumocin expression, immunity and the inducer peptide BlpC, are pH-dependent and induced in the late exponential phase. Intriguingly, competence for genetic transformation, mediated by the paralogous ComD/E two-component quorum system, is induced by the same environmental cues. To test for interplay between these regulatory systems, we quantified the regulatory response to the addition of synthetic BlpC and competence-stimulating peptide (CSP). Supporting the idea of such interplay, we found that immediately upon addition of CSP, the blp-promoters were activated in a comD/E-dependent manner. After a delay, blp-expression was highly induced and was strictly dependent on blpRH and blpC. This raised the question of the mechanism of BlpC export, since bioinformatic analysis showed that the genes encoding the putative exporter for BlpC, blpAB, are not intact in strain D39 and most other strains. By contrast, all sequenced pneumococcal strains contain intact comAB genes, encoding the transport system for CSP. Consistent with the idea that comAB mediate BlpC export, we finally show that high-level expression of the blp-genes requires comAB. Together, our results demonstrate that regulation of pneumocin expression is intertwined with competence, explaining why certain antibiotics induce blp-expression. Antibiotic-induced pneumocin expression might therefore have unpredictable consequences on pneumococcal colonization dynamics by activating genes that mediate intra-specific interference competition. Streptococcus pneumoniae is an opportunistic pathogen with high carriage rates in children. Pneumococci express pneumocins that kill competing bacteria. Pneumocin expression is controlled by a pheromone-induced two-component system (BlpR/H) but the triggers for the system are poorly understood. We show that the pheromone-induced two-component system driving competence for genetic transformation, ComD/E, also controls expression of BlpC, the peptide pheromone activating BlpR/H-dependent gene expression. Importantly, we show that the competence pheromone exporter, ComAB, also exports BlpC. Since antibiotics that disrupt protein quality control or DNA replication trigger competence, it follows that the same antibiotics activate pneumocin expression. Our experiments show that this dual-quorum sensing system ensures that pneumocins are expressed at the end of exponential growth when nutrients become limiting. Pneumocin expression might thus be used to liberate nutrients by lysing competing bacteria. Antibiotic-induced pneumocin production might also aid in clearing the niche after antibiotic stress. Any free DNA can then be used for transformation to acquire antibiotic-resistance.

12 December 2020 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
GMGemma Murray
Gemma Murray
JCJane Charlesworth
Jane Charlesworth
EMEric Miller
Eric Miller
MCMichael J Casey
Michael J Casey
CLCatrin T Lloyd
Catrin T Lloyd
LWLucy A Weinert
Lucy A Weinert
Emerging bacterial pathogens threaten global health and food security, and so it is important to ask whether these transitions to pathogenicity have any common features. We present a systematic study of the claim that pathogenicity is associated with genome reduction and gene loss. We compare broad-scale patterns across all bacteria, with detailed analyses of Streptococcus suis, an emerging zoonotic pathogen of pigs, which has undergone multiple transitions between disease and carriage forms. We find that pathogenicity is consistently associated with reduced genome size across three scales of divergence (between species within genera, and between and within genetic clusters of S. suis). Although genome reduction is also found in mutualist and commensal bacterial endosymbionts, genome reduction in pathogens cannot be solely attributed to the features of their ecology that they share with these species, that is, host restriction or intracellularity. Moreover, other typical correlates of genome reduction in endosymbionts (reduced metabolic capacity, reduced GC content, and the transient expansion of nonfunctional elements) are not consistently observed in pathogens. Together, our results indicate that genome reduction is a consistent correlate of pathogenicity in bacteria.

19 October 2016 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Open access
OAOle Herman Ambur
Ole Herman Ambur
JEJan Engelstädter
Jan Engelstädter
PJPål J. Johnsen
Pål J. Johnsen
EMEric Miller
Eric Miller
DRDaniel E. Rozen
Daniel E. Rozen
Many bacteria are highly sexual, but the reasons for their promiscuity remain obscure. Did bacterial sex evolve to maximize diversity and facilitate adaptation in a changing world, or does it instead help to retain the bacterial functions that work right now? In other words, is bacterial sex innovative or conservative? Our aim in this review is to integrate experimental, bioinformatic and theoretical studies to critically evaluate these alternatives, with a main focus on natural genetic transformation, the bacterial equivalent of eukaryotic sexual reproduction. First, we provide a general overview of several hypotheses that have been put forward to explain the evolution of transformation. Next, we synthesize a large body of evidence highlighting the numerous passive and active barriers to transformation that have evolved to protect bacteria from foreign DNA, thereby increasing the likelihood that transformation takes place among clonemates. Our critical review of the existing literature provides support for the view that bacterial transformation is maintained as a means of genomic conservation that provides direct benefits to both individual bacterial cells and to transformable bacterial populations. We examine the generality of this view across bacteria and contrast this explanation with the different evolutionary roles proposed to maintain sex in eukaryotes. This article is part of the themed issue ‘Weird sex: the underappreciated diversity of sexual reproduction’.

7 September 2021 in BMC Biology
Verified
Journal Article
Open access
PDF file
NHNazreen F. Hadjirin
Nazreen F. Hadjirin
EMEric Miller
Eric Miller
GMGemma G. R. Murray
Gemma G. R. Murray
PYPhung L. K. Yen
Phung L. K. Yen
HPHo D. Phuc
Ho D. Phuc
LWLucy A. Weinert
Lucy A. Weinert
Background: Antimicrobial resistance (AMR) is among the gravest threats to human health and food security worldwide. The use of antimicrobials in livestock production can lead to emergence of AMR, which can have direct effects on humans through spread of zoonotic disease. Pigs pose a particular risk as they are a source of zoonotic diseases and receive more antimicrobials than most other livestock. Here we use a large-scale genomic approach to characterise AMR inStreptococcus suis, a commensal found in most pigs, but which can also cause serious disease in both pigs and humans.Results: We obtained replicated measures of Minimum Inhibitory Concentration (MIC) for 16 antibiotics, across a panel of 678 isolates, from the major pig-producing regions of the world. For several drugs, there was no natural separation into ‘resistant’ and ‘susceptible’, highlighting the need to treat MIC as a quantitative trait. We found differences in MICs between countries, consistent with their patterns of antimicrobial usage. AMR levels were high even for drugs not used to treatS. suis, with many multidrug-resistant isolates. Similar levels of resistance were found in pigs and humans from regions associated with zoonotic transmission. We next used whole genome sequences for each isolate to identify 43 candidate resistance determinants, 22 of which were novel inS. suis. The presence of these determinants explained most of the variation in MIC. But there were also interesting complications, including epistatic interactions, where known resistance alleles had no effect in some genetic backgrounds. Beta-lactam resistance involved many core genome variants of small effect, appearing in a characteristic order.Conclusions: We present a large dataset allowing the analysis of the multiple contributing factors to AMR inS. suis. The high levels of AMR inS. suisthat we observe are reflected by antibiotic usage patterns but our results confirm the potential for genomic data to aid in the fight against AMR.